✦ LIBER ✦

Keratin 17: a useful marker in anti-psoriatic therapies

✍ Scribed by E. M. G. J. Jong; I. M. M. J. Vlijmen; P. E. J. Erp; F. C. S. Ramaekers; S. M. Troyanovski; P. C. M. Kerkhof

Publisher: Springer-Verlag
Year: 1991
Tongue: English
Weight: 550 KB
Volume: 283
Category: Article
ISSN: 0340-3696
DOI: 10.1007/bf00371788

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvements in quality of life and func

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies

✍ Amr A. Saad; Darren M. Ashcroft; Kath D. Watson; Deborah P. M. Symmons; Peter R. 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 100 KB 👁 2 views

A study of surface markers in acute lymp

A study of surface markers in acute lymphocytic leukemia by using anti-T and anti-B lymphocyte sera

✍ Noboru Yamanaka; Yoshifumi Ishii; Hirofumi Koshiba; Chikara Mikuni; Mutsuko Konn 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

A study of surface markers in non--Hodgk

A study of surface markers in non--Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera

✍ Noboru Yamanaka; Yoshifumi Ishii; Hirofumi Koshiba; Chikara Mikuni; Minoru Ogasa 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Free circulating soluble CD52 as a tumor

Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies

✍ Maher Albitar; Kim-Anh Do; Marcella M. Johnson; Francis J. Giles; Iman Jilani; S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

## Abstract ## BACKGROUND The CD52 antigen is a glycoprotein anchored on the cell membrane of mature B and T lymphocytes, monocytes, and eosinophils. Alemtuzumab (CAMPATH‐1H; anti‐CD52) is currently approved for the treatment of patients with refractory chronic lymphocytic leukemia (CLL). The auth

Anti IL-17A therapy inhibits bone loss i

Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance

✍ Karin Zwerina; Marije Koenders; Axel Hueber; Renoud J. Marijnissen; Wolfgang Bau 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

## Abstract Tumour necrosis factor alpha (TNF‐α) is a major inducer for inflammation and bone loss. Here, we investigated whether interleukin (IL)‐17 plays a role in TNF‐α‐mediated inflammation and bone resorption. Human TNF‐α transgenic (hTNFtg) mice were treated with a neutralizing anti‐IL‐17A an

Use of anti-CD40 ligand monoclonal antib

Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model

✍ John N. Jensen; Thomas H.H. Tung; Susan E. Mackinnon; Michael J. Brenner; Daniel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB

Monoclonal antibody directed against CD40 ligand prevents acute allograft rejection in several models of solid-organ transplantation. This study describes the use of CD40 ligand as antirejection therapy in a mouse peripheral nerve allograft model. C3H mice received 8-mm nerve isografts (n = 2) or ne